Study Details

General Information

AstraZeneca Asthma D3250C00017

ProtocolD3250C00017
IdentifierD3250C00017
UID21695668-434b-4415-86b8-4cbef9ceb877
StatusPI Declined
Phase
CategoryAsthma
Launch Year0
NCT Number-
Created2014-08-27 11:16
Last Updated2014-08-27 11:16

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMoon, MiaMMoonNo
Recruiter-No
CoordinatorSoler, DanielDSolerNo
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorAstraZeneca Pharmaceuticals
DivisionAstraZeneca Pharamecuticals
TeamAstraZeneca Pharamecuticals LP
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROParexel International
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGray
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?